mainstream reporters and editors and publishers are well aware that telling the truth and continuing to pound on it would undermine a basic institution of society...

may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.

richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.